MacDonald BT et al. (2009), Wnt/beta-catenin signaling: components, mechani...

XB-ART-60536

Dev Cell 2009 Jul 01;171:9-26. doi: 10.1016/j.devcel.2009.06.016.

Show Gene links Show Anatomy links

Wnt/beta-catenin signaling: components, mechanisms, and diseases.

MacDonald BT , Tamai K , He X .

???displayArticle.abstract???
Signaling by the Wnt family of secreted glycolipoproteins via the transcriptional coactivator beta-catenin controls embryonic development and adult homeostasis. Here we review recent progress in this so-called canonical Wnt signaling pathway. We discuss Wnt ligands, agonists, and antagonists, and their interactions with Wnt receptors. We also dissect critical events that regulate beta-catenin stability, from Wnt receptors to the cytoplasmic beta-catenin destruction complex, and nuclear machinery that mediates beta-catenin-dependent transcription. Finally, we highlight some key aspects of Wnt/beta-catenin signaling in human diseases including congenital malformations, cancer, and osteoporosis, and discuss potential therapeutic implications.

???displayArticle.pubmedLink??? 19619488
???displayArticle.pmcLink??? PMC2861485
???displayArticle.link??? Dev Cell
???displayArticle.grants??? [+]

Species referenced: Xenopus tropicalis Xenopus laevis
Genes referenced: apc axin1 cer1 ctnnb1 dkk1 fzd1 fzd4 gsk3a gsk3b lrp5 lrp6 macf1 ndp npy4r ptpa rspo1 wls wnt1 wnt3a
GO keywords: receptor-mediated endocytosis [+]

???displayArticle.disOnts??? tetraamelia syndrome
???displayArticle.omims??? COLORECTAL CANCER; CRC [+]

???attribute.lit??? ???displayArticles.show???

	Figure 1. Overview of Wnt/β-Catenin Signaling (A) In the absence of Wnt, cytoplasmic β-catenin forms a complex with Axin, APC, GSK3, and CK1, and is phosphorylated by CK1 (blue) and subsequently by GSK3 (yellow). Phosphorylated β-catenin is recognized by the E3 ubiquitin ligase β-Trcp, which targets β-catenin for proteosomal degradation. Wnt target genes are repressed by TCF-TLE/Groucho and histone deacetylases (HDAC). (B) In the presence of Wnt ligand, a receptor complex forms between Fz and LRP5/6. Dvl recruitment by Fz leads to LRP5/6 phosphorylation and Axin recruitment. This disrupts Axin-mediated phosphorylation/degradation of β-catenin, allowing β-catenin to accumulate in the nucleus where it serves as a coactivator for TCF to activate Wnt-responsive genes.
	Figure 2. Wnt Biogenesis and Secretion Wnts are glycosylated and lipid modified in the ER, which involves Porcupine and are escorted by Wntless from the Golgi to the plasma membrane for secretion. Wntless is retrieved from endocytic vescicles and brought back to the Golgi by the retromer complex. After secretion mature Wnts either bind to HSPGs and lipoprotein particles or form multimers, which can modulate Wnt gradients and facilitate long-range Wnt signaling. The numbers of Wnt molecules bound to the lipoprotein particle and composed in multimeric form were drawn arbitrarily.
	Figure 3. Secreted Wnt Antagonists and Agonists (A) Antagonists. WIF and sFRP bind directly to secreted Wnts and/or Fz. DKK and SOST/WISE proteins bind LRP5/6 to prevent Fz-LRP6 complex formation. Shisa proteins trap Fz in the ER. (B) Agonists. Wnts are the primary agonists and form a complex with LRP5/6 and Fz to activate signaling. Norrin acts similarly to Wnt, but binds specifically to FZD4. R-spondin proteins (Rspo) act via and may bind to LRP5/6 and/or Fz receptors. In the ER, the chaperone MESD is needed for LRP5/6 maturation.
	Figure 4. Regulation of Axin Complex Assembly for β-Catenin Degradation. The core components of the Axin complex—Axin, APC, GSK3 and CK1—collectively promote β-catenin phosphorylation for degradation by β-Trcp. In addition to phosphorylating β-catenin, GSK3 (yellow) and CK1 (blue) also phosphorylate Axin and APC and enhance their binding to β-catenin and degradation complex stability, further ensuring β-catenin phosphorylation. The inset illustrates β-catenin phosphorylation (by CK1 and GSK3) and dephosphorylation (by PP2A). APC may also act to prevent PP2A dephosphorylation of β-catenin. APC paradoxically facilitates Axin degradation and possibly vice versa (indicated by dashed line, see text). PP1 dephosphorylates Axin to antagonize CK1 phosphorylation and negatively regulates GSK3-Axin binding, resulting in complex disassembly.
	Figure 5. Models of Wnt Receptor Activation A) Initiation and amplification. Wnt forms a complex with LRP6 and Fz-Dvl at the membrane. Dvl recruits Axin-GSK3, resulting in the phosphorylation of one or more PPPSP motifs in LRP6 (initiation). Partially phosphorylated LRP6 may be able to recruit and more efficiently bind Axin-GSK3 and promote more PPPSP phosphorylation (amplification). (B) Signalsome formation via Dvl polymerization and receptor clustering. The oligiomerization property of Dvl promotes the aggregation of individual Wnt-LRP6-Fz complexes, resulting in Axin recruitment to the membrane and LRP6 phosphorylation by GSK3 and CK1. (C) PI4KIIα and PIP5KI kinases, the latter of which binds directly with Dvl and promote PIP2 production and receptor clustering/phosphorylation. The configurations of receptor clustering in (B) and (C) were drawn arbitrarily. In all models, PPPSPxS motifs are sequentially phosphorylated by GSK3 and CK1, probably via CK1γ (membrane-associated) and/or CK1α and CK1ɛ associated with Axin and Dvl, respectively, and MACF1 may have a role in the translocation of the Axin complex to the receptors.

References [+] :

Adaimy, Mutation in WNT10A is associated with an autosomal recessive ectodermal dysplasia: the odonto-onycho-dermal dysplasia. 2007, Pubmed

Adaimy, Mutation in WNT10A is associated with an autosomal recessive ectodermal dysplasia: the odonto-onycho-dermal dysplasia. 2007, Pubmed
Ai, Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. 2005, Pubmed
Angers, The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. 2006, Pubmed , Xenbase
Arce, Diversity of LEF/TCF action in development and disease. 2006, Pubmed
Atcha, A unique DNA binding domain converts T-cell factors into strong Wnt effectors. 2007, Pubmed
Baig-Lewis, Wingless/Wnt signal transduction requires distinct initiation and amplification steps that both depend on Arrow/LRP. 2007, Pubmed
Balemans, Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). 2001, Pubmed
Balemans, Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. 2002, Pubmed
Barker, Mining the Wnt pathway for cancer therapeutics. 2006, Pubmed
Behrens, Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. 1998, Pubmed , Xenbase
Belenkaya, The retromer complex influences Wnt secretion by recycling wntless from endosomes to the trans-Golgi network. 2008, Pubmed
Bell, R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. 2008, Pubmed
Benchabane, Adenomatous polyposis coli is present near the minimal level required for accurate graded responses to the Wingless morphogen. 2008, Pubmed
Bergmann, Mutations in the gene encoding the Wnt-signaling component R-spondin 4 (RSPO4) cause autosomal recessive anonychia. 2006, Pubmed
Biason-Lauber, A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46,XX woman. 2004, Pubmed
Bilic, Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. 2007, Pubmed
Binnerts, R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. 2007, Pubmed
Björklund, An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling. 2007, Pubmed
Blauwkamp, Novel TCF-binding sites specify transcriptional repression by Wnt signalling. 2008, Pubmed
Blaydon, The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia. 2006, Pubmed
Bodine, A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation. 2009, Pubmed
Bovolenta, Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. 2008, Pubmed
Boyden, High bone density due to a mutation in LDL-receptor-related protein 5. 2002, Pubmed
Brembeck, Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. 2004, Pubmed
Brunkow, Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. 2001, Pubmed
Bryja, The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo. 2009, Pubmed , Xenbase
Carrera, Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 and Med13. 2008, Pubmed
Castellone, Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. 2005, Pubmed
Chamorro, FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. 2005, Pubmed , Xenbase
Chang, Activation of wingless targets requires bipartite recognition of DNA by TCF. 2008, Pubmed
Chen, Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. 2009, Pubmed
Chen, The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. 2006, Pubmed
Ching, Lipid-independent secretion of a Drosophila Wnt protein. 2008, Pubmed
Choi, Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin. 2004, Pubmed , Xenbase
Christodoulides, WNT10B mutations in human obesity. 2006, Pubmed
Clevers, Wnt/beta-catenin signaling in development and disease. 2006, Pubmed
Cliffe, A role of Dishevelled in relocating Axin to the plasma membrane during wingless signaling. 2003, Pubmed
Cong, Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. 2004, Pubmed
Cong, Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. 2004, Pubmed
Cselenyi, LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin. 2008, Pubmed , Xenbase
Daniels, Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. 2005, Pubmed
Davidson, Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. 2005, Pubmed , Xenbase
De Ferrari, The ups and downs of Wnt signaling in prevalent neurological disorders. 2006, Pubmed
DeAlmeida, The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. 2007, Pubmed
Diarra, Dickkopf-1 is a master regulator of joint remodeling. 2007, Pubmed
Ding, Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6 phosphorylation. 2008, Pubmed
Doble, Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. 2007, Pubmed
Ellies, Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. 2006, Pubmed , Xenbase
Ellwanger, Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density. 2008, Pubmed
Emami, A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. 2004, Pubmed
Esufali, Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. 2004, Pubmed
Fang, C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila. 2006, Pubmed
Fiedler, Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex. 2008, Pubmed
Firestein, CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. 2008, Pubmed
Florez, TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. 2006, Pubmed
Franch-Marro, In vivo role of lipid adducts on Wingless. 2008, Pubmed
Franch-Marro, Wingless secretion requires endosome-to-Golgi retrieval of Wntless/Evi/Sprinter by the retromer complex. 2008, Pubmed
Fuchs, The tortoise and the hair: slow-cycling cells in the stem cell race. 2009, Pubmed
Gagliardi, Endocytosis: a positive or a negative influence on Wnt signalling? 2008, Pubmed
Galli, Porcupine-mediated lipid-modification regulates the activity and distribution of Wnt proteins in the chick neural tube. 2007, Pubmed
Gan, Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. 2008, Pubmed
Gerdes, The vertebrate primary cilium in development, homeostasis, and disease. 2009, Pubmed
Goessling, Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. 2009, Pubmed
Gong, LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. 2001, Pubmed
Grant, Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. 2006, Pubmed
Grzeschik, Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. 2007, Pubmed
Ha, Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. 2004, Pubmed
Hamada, The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. 2004, Pubmed
Hatzis, Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. 2008, Pubmed
Hausmann, Helping Wingless take flight: how WNT proteins are secreted. 2007, Pubmed
He, Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. 2005, Pubmed
He, LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. 2004, Pubmed
Henderson, The ins and outs of APC and beta-catenin nuclear transport. 2002, Pubmed
Hendriksen, RanBP3 enhances nuclear export of active (beta)-catenin independently of CRM1. 2005, Pubmed , Xenbase
Hendriksen, Plasma membrane recruitment of dephosphorylated beta-catenin upon activation of the Wnt pathway. 2008, Pubmed , Xenbase
Hoffmans, Pygopus and legless provide essential transcriptional coactivator functions to armadillo/beta-catenin. 2005, Pubmed
Holmen, Wnt-independent activation of beta-catenin mediated by a Dkk1-Fz5 fusion protein. 2005, Pubmed
Hoppler, Wnt signalling: variety at the core. 2007, Pubmed
Huang, Wnt/beta-catenin signaling: new (and old) players and new insights. 2008, Pubmed
Itasaki, Wise, a context-dependent activator and inhibitor of Wnt signalling. 2003, Pubmed , Xenbase
Itoh, Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling. 2005, Pubmed , Xenbase
Jamora, Links between signal transduction, transcription and adhesion in epithelial bud development. 2003, Pubmed
Kahler, Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. 2003, Pubmed
Kanazawa, Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes. 2004, Pubmed
Katanaev, Trimeric G protein-dependent frizzled signaling in Drosophila. 2005, Pubmed
Katanaev, Reggie-1/flotillin-2 promotes secretion of the long-range signalling forms of Wingless and Hedgehog in Drosophila. 2008, Pubmed
Kazanskaya, R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. 2004, Pubmed , Xenbase
Khan, Analysis of endogenous LRP6 function reveals a novel feedback mechanism by which Wnt negatively regulates its receptor. 2007, Pubmed
Kim, Mitogenic influence of human R-spondin1 on the intestinal epithelium. 2005, Pubmed
Kimelman, beta-catenin destruction complex: insights and questions from a structural perspective. 2006, Pubmed
Kinzler, Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. 1991, Pubmed
Komekado, Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a. 2007, Pubmed
Korinek, Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. 1997, Pubmed
Krieghoff, Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. 2006, Pubmed
Lammi, Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. 2004, Pubmed
Lee, The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. 2003, Pubmed , Xenbase
Lepourcelet, Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. 2004, Pubmed , Xenbase
Li, Chibby cooperates with 14-3-3 to regulate beta-catenin subcellular distribution and signaling activity. 2008, Pubmed
Li, TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis. 2008, Pubmed
Li, Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. 2005, Pubmed
Lin, Functions of heparan sulfate proteoglycans in cell signaling during development. 2004, Pubmed
Little, A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. 2002, Pubmed
Liu, G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway. 2001, Pubmed , Xenbase
Liu, Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. 2000, Pubmed
Liu, Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. 2005, Pubmed
Logan, The Wnt signaling pathway in development and disease. 2004, Pubmed
Luo, Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. 2007, Pubmed , Xenbase
Luo, Axin contains three separable domains that confer intramolecular, homodimeric, and heterodimeric interactions involved in distinct functions. 2005, Pubmed
MacDonald, Wnt signal amplification via activity, cooperativity, and regulation of multiple intracellular PPPSP motifs in the Wnt co-receptor LRP6. 2008, Pubmed , Xenbase
Major, Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. 2007, Pubmed , Xenbase
Mani, LRP6 mutation in a family with early coronary disease and metabolic risk factors. 2007, Pubmed
Mao, Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. 2002, Pubmed
Mao, Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. 2001, Pubmed
Mao, Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. 2009, Pubmed
Mi, The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity. 2006, Pubmed
Mieszczanek, A role of Pygopus as an anti-repressor in facilitating Wnt-dependent transcription. 2008, Pubmed
Mizumoto, Two betas or not two betas: regulation of asymmetric division by beta-catenin. 2007, Pubmed
Morin, Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. 1997, Pubmed
Morrell, Liposomal packaging generates Wnt protein with in vivo biological activity. 2008, Pubmed
Morris, E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. 2008, Pubmed
Mosimann, Beta-catenin hits chromatin: regulation of Wnt target gene activation. 2009, Pubmed
Nam, Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression. 2006, Pubmed
Niemann, Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family. 2004, Pubmed
Nishisho, Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. 1991, Pubmed
Nusse, Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. 1982, Pubmed
Oates, Increased DNA methylation at the AXIN1 gene in a monozygotic twin from a pair discordant for a caudal duplication anomaly. 2006, Pubmed
Olson, Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. 2006, Pubmed
Pan, C. elegans AP-2 and retromer control Wnt signaling by regulating mig-14/Wntless. 2008, Pubmed
Pan, Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation. 2008, Pubmed , Xenbase
Panáková, Lipoprotein particles are required for Hedgehog and Wingless signalling. 2005, Pubmed
Parker, Wingless signaling induces widespread chromatin remodeling of target loci. 2008, Pubmed
Parma, R-spondin1 is essential in sex determination, skin differentiation and malignancy. 2006, Pubmed
Peterson-Nedry, Unexpectedly robust assembly of the Axin destruction complex regulates Wnt/Wg signaling in Drosophila as revealed by analysis in vivo. 2008, Pubmed
Piao, Direct inhibition of GSK3beta by the phosphorylated cytoplasmic domain of LRP6 in Wnt/beta-catenin signaling. 2008, Pubmed , Xenbase
Piccolo, The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. 1999, Pubmed , Xenbase
Piepenburg, Drosophila segment borders result from unilateral repression of hedgehog activity by wingless signaling. 2000, Pubmed
Polakis, The many ways of Wnt in cancer. 2007, Pubmed
Port, Wingless secretion promotes and requires retromer-dependent cycling of Wntless. 2008, Pubmed
Price, CKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling. 2006, Pubmed
Rivera, An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. 2007, Pubmed
Robitaille, Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. 2002, Pubmed , Xenbase
Salic, Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. 2000, Pubmed , Xenbase
Satoh, AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. 2000, Pubmed
Satoh, Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse. 2008, Pubmed
Schlessinger, Wnt signaling pathways meet Rho GTPases. 2009, Pubmed , Xenbase
Schwab, Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development. 2007, Pubmed
Schwarz-Romond, The ankyrin repeat protein Diversin recruits Casein kinase Iepsilon to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling. 2002, Pubmed , Xenbase
Schwarz-Romond, The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization. 2007, Pubmed
Schwarz-Romond, Dynamic recruitment of axin by Dishevelled protein assemblies. 2007, Pubmed
Seifert, Frizzled/PCP signalling: a conserved mechanism regulating cell polarity and directed motility. 2007, Pubmed
Semenov, LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. 2006, Pubmed
Semënov, SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. 2005, Pubmed , Xenbase
Semënov, Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. 2001, Pubmed , Xenbase
Semënov, DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. 2008, Pubmed
Shan, Identification of a specific inhibitor of the dishevelled PDZ domain. 2005, Pubmed , Xenbase
Shao, Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. 2005, Pubmed
Sierra, The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. 2006, Pubmed
Simons, Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. 2005, Pubmed , Xenbase
Sotgia, Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling. 2005, Pubmed
Städeli, Transcription under the control of nuclear Arm/beta-catenin. 2006, Pubmed
Su, APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP ubiquitin ligase. 2008, Pubmed , Xenbase
Sustmann, Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin. 2008, Pubmed
Suzuki, Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. 2004, Pubmed
Tago, Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. 2000, Pubmed , Xenbase
Tahinci, Lrp6 is required for convergent extension during Xenopus gastrulation. 2007, Pubmed , Xenbase
Takacs, Dual positive and negative regulation of wingless signaling by adenomatous polyposis coli. 2008, Pubmed
Takada, Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. 2006, Pubmed , Xenbase
Tamai, A mechanism for Wnt coreceptor activation. 2004, Pubmed , Xenbase
Tanaka, Drosophila segment polarity gene product porcupine stimulates the posttranslational N-glycosylation of wingless in the endoplasmic reticulum. 2002, Pubmed
Theisen, Wingless directly represses DPP morphogen expression via an armadillo/TCF/Brinker complex. 2007, Pubmed
Tolwinski, Wg/Wnt signal can be transmitted through arrow/LRP5,6 and Axin independently of Zw3/Gsk3beta activity. 2003, Pubmed
Toomes, Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. 2004, Pubmed
Torres, Colocalization and redistribution of dishevelled and actin during Wnt-induced mesenchymal morphogenesis. 2000, Pubmed
Townsley, Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function. 2004, Pubmed
Vlad, The first five years of the Wnt targetome. 2008, Pubmed
Wallingford, The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. 2005, Pubmed
Wan, Parathyroid hormone signaling through low-density lipoprotein-related protein 6. 2008, Pubmed , Xenbase
Wang, Characterization of the Kremen-binding site on Dkk1 and elucidation of the role of Kremen in Dkk-mediated Wnt antagonism. 2008, Pubmed
Wang, CK2 controls the recruitment of Wnt regulators to target genes in vivo. 2006, Pubmed
Wang, Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia. 2007, Pubmed
Wang, Tissue/planar cell polarity in vertebrates: new insights and new questions. 2007, Pubmed
Wehrli, arrow encodes an LDL-receptor-related protein essential for Wingless signalling. 2000, Pubmed
Wei, R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling. 2007, Pubmed , Xenbase
Welters, Wnt signaling: relevance to beta-cell biology and diabetes. 2008, Pubmed
Willert, Wnt proteins are lipid-modified and can act as stem cell growth factors. 2003, Pubmed , Xenbase
Willert, Wnt signaling: is the party in the nucleus? 2006, Pubmed
Willert, Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex. 1999, Pubmed
Williams, Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. 2009, Pubmed
Wolf, Multiple PPPS/TP motifs act in a combinatorial fashion to transduce Wnt signaling through LRP6. 2008, Pubmed
Wong, Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. 2003, Pubmed , Xenbase
Woods, Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome. 2006, Pubmed
Wu, Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6. 2009, Pubmed , Xenbase
Wu, Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. 2008, Pubmed
Xing, Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex. 2003, Pubmed , Xenbase
Xu, Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. 2004, Pubmed
Yaccoby, Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. 2007, Pubmed
Yadav, Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. 2008, Pubmed
Yamamoto, Shisa promotes head formation through the inhibition of receptor protein maturation for the caudalizing factors, Wnt and FGF. 2005, Pubmed , Xenbase
Yamamoto, Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. 1999, Pubmed
Yamamoto, Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin. 2006, Pubmed
Yang, Wnt signaling requires retromer-dependent recycling of MIG-14/Wntless in Wnt-producing cells. 2008, Pubmed
Zeng, Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. 2008, Pubmed , Xenbase
Zeng, A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. 2005, Pubmed , Xenbase
Zhai, Drosophila wnt-1 undergoes a hydrophobic modification and is targeted to lipid rafts, a process that requires porcupine. 2004, Pubmed
Zhang, Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. 2006, Pubmed , Xenbase
Zhang, Inhibition of Wnt signaling by Dishevelled PDZ peptides. 2009, Pubmed
Zhu, IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. 2008, Pubmed , Xenbase
de la Roche, Wingless-independent association of Pygopus with dTCF target genes. 2007, Pubmed
van Amerongen, Alternative wnt signaling is initiated by distinct receptors. 2008, Pubmed